Myo-inositol is a naturally occurring sugar alcohol — technically a carbocyclic polyol — found in foods like citrus fruits, cantaloupe, nuts, and whole grains. It is also synthesized in the body from glucose. Despite being a relatively simple molecule, inositol plays a critical role in multiple cellular signaling pathways, which explains why it has demonstrated clinical effects across such a wide range of conditions.
Understanding how to use myo-inositol effectively requires knowing that the dose differs dramatically depending on what you're treating — a 2g dose for PCOS is very different from the 12-18g studied for certain psychiatric conditions. This guide breaks down what the research supports and how to apply it.
How myo-inositol works
Inositol is a component of phosphatidylinositol, a key phospholipid in cell membranes. When cells receive signaling molecules — insulin, FSH, TSH — inositol-containing second messengers transmit that signal intracellularly. If inositol availability is limited or cellular inositol metabolism is disrupted, receptor signaling becomes impaired even when hormone levels appear normal.
This insulin-sensitizing mechanism is the foundation for myo-inositol's effects in PCOS. It also explains the TSH connection in thyroid tissue and the role of inositol-mediated signaling in serotonin and other neurotransmitter pathways.
The two forms: Myo-inositol (MI) and D-chiro-inositol (DCI) are the two primary isomers relevant to health. They are interconverted in the body by an enzyme called epimerase, and the optimal ratio in the ovary is 40:1 MI:DCI. Most PCOS-specific supplements now use this 40:1 ratio, which is discussed further below.
PCOS: the best-established application
Polycystic ovary syndrome is characterized by insulin resistance, hyperandrogenism, and ovulatory dysfunction. Inositol-mediated insulin signaling is disrupted in PCOS, and restoring it with myo-inositol supplementation has been shown to improve multiple PCOS-related parameters.
Standard dose for PCOS: 2g myo-inositol twice daily (4g total), often combined with 50mg D-chiro-inositol (a 40:1 ratio), plus 400mcg folic acid.
Evidence: Multiple systematic reviews and meta-analyses have evaluated myo-inositol in PCOS. Consistent findings include:
- Restoration of ovulatory cycles in 65-70% of women who were anovulatory
- Reduction in fasting insulin and HOMA-IR (insulin resistance marker)
- Reduction in free androgen index and testosterone
- Improvements in antral follicle count and oocyte quality in IVF settings
- LH/FSH ratio normalization
Comparison to metformin: A 2019 comparative trial found that myo-inositol (4g/day) produced similar improvements in menstrual regularity and metabolic markers as metformin 1500mg/day, with significantly fewer gastrointestinal side effects. Inositol is not a pharmaceutical, but it is clinically meaningful in PCOS.
The 40:1 ratio caution: Higher doses of D-chiro-inositol relative to myo-inositol (ratios lower than 40:1) have been shown to impair oocyte quality in women undergoing IVF by over-converting inositol in ovarian tissue. The 40:1 MI:DCI ratio most closely mirrors the natural ovarian ratio and is the formulation with the best evidence.
Subclinical hypothyroidism and Hashimoto's
A notable and less-widely-known application of myo-inositol is in subclinical hypothyroidism, particularly in the context of autoimmune thyroid disease.
TSH receptor signaling in thyroid cells relies on inositol-mediated second messenger pathways. In people with Hashimoto's thyroiditis, inositol metabolism in thyroid tissue may be disrupted, impairing the gland's response to TSH stimulation.
Key trial: A 2013 Italian randomized controlled trial compared selenium (83mcg) alone, myo-inositol (600mg) alone, and their combination in women with subclinical hypothyroidism and Hashimoto's. After 6 months, the combination group showed:
- Normalization of TSH (from subclinical to normal range) in significantly more patients
- Greater reduction in TPO antibodies than either treatment alone
- Improved thyroid echogenicity on ultrasound
Subsequent work has replicated this finding. The selenium + myo-inositol combination appears to have synergistic effects on TSH normalization that neither compound achieves as effectively alone.
Dose in this context: 600mg myo-inositol daily alongside selenium 200mcg. This is far lower than PCOS dosing.
Anxiety and panic disorder
Myo-inositol has been studied at high doses (12-18g/day) for anxiety and panic disorder, based on the hypothesis that inositol depletion may impair serotonergic and noradrenergic signaling.
Panic disorder trial: A double-blind crossover trial published in the American Journal of Psychiatry compared 18g/day inositol to fluvoxamine (an SSRI) in 20 patients with panic disorder. Inositol reduced the frequency of panic attacks by 4 per week versus 2.4 per week for fluvoxamine, with fewer side effects. This is a small study but remarkable for a nutrient comparison to a pharmaceutical.
OCD: A double-blind crossover trial found 18g/day inositol significantly reduced Yale-Brown Obsessive Compulsive Scale scores compared to placebo, though effects were modest.
Important note: These effects were seen at doses 3-9 times higher than those used for PCOS. Inositol is water-soluble and well-tolerated at high doses, with loose stools being the most common dose-limiting side effect (typically resolved by dividing doses throughout the day or dose-titrating up over 2-4 weeks).
Depression
The evidence for myo-inositol in depression is mixed. Early trials were promising — a crossover trial showed 12g/day significantly outperformed placebo on the Hamilton Depression Rating Scale. However, subsequent trials, including one adding inositol to SSRIs in treatment-resistant depression, showed no additional benefit.
The current reading of the literature is that inositol may have antidepressant effects as monotherapy in mild-to-moderate depression, but does not augment SSRI therapy in treatment-resistant cases. Not a primary recommendation for depression, but a reasonable adjunct to discuss with a prescriber.
Premenstrual syndrome and PMDD
Inositol depletion has been proposed in the luteal phase of the menstrual cycle in women with PMS. Small trials using 2-4g/day have shown reductions in mood symptoms, irritability, and food cravings in PMS, though the evidence base is limited. May be worth trialing for PMDD as part of a broader intervention while more robust data emerges.
Practical dosing summary
| Condition | Dose | Ratio | |-----------|------|-------| | PCOS | 4g/day (2g twice daily) | 40:1 MI:DCI recommended | | Thyroid / Hashimoto's | 600mg/day | Myo-inositol only | | Anxiety / Panic | 12-18g/day | Myo-inositol only | | OCD | 18g/day | Myo-inositol only | | PMS | 2-4g/day | Myo-inositol only |
Safety profile
Myo-inositol has an excellent safety record across trials lasting up to 12 months. The primary side effects are gastrointestinal: loose stools, nausea, and bloating, which are dose-dependent and typically manageable by titrating up slowly. It is considered safe in pregnancy (used in some trials for gestational diabetes prevention) and while breastfeeding, though always discuss with an obstetrician.
The bottom line
Myo-inositol's versatility stems from its role in fundamental cell signaling pathways. For PCOS, 4g/day in a 40:1 MI:DCI ratio has the most robust evidence. For subclinical hypothyroidism with Hashimoto's, 600mg combined with selenium shows promise for TSH normalization. For anxiety and OCD, high-dose inositol (12-18g/day) has intriguing but limited trial evidence. Know your target condition and dose accordingly — the range is enormous.
Log your inositol dose and track PCOS or thyroid symptoms over time. Use Optimize free.
Related Articles
Related Supplement Interactions
Learn how these supplements interact with each other
Related Articles
More evidence-based reading
Akkermansia Muciniphila: The Gut Bacteria That Affects Metabolism and Weight
Akkermansia muciniphila is a keystone gut bacterium whose abundance strongly predicts metabolic health, gut barrier integrity, and response to weight loss interventions — and it can be deliberately cultivated.
8 min read →Resistant Starch for Gut Health: The Prebiotic That Changes Body Composition
Resistant starch is one of the few dietary compounds with simultaneous evidence for improving gut microbiome diversity, reducing postprandial glucose, and improving body composition — through mechanisms that are now well understood.
9 min read →Butyrate Supplements: What This Short-Chain Fatty Acid Does for Your Gut
Butyrate is the primary fuel source for colon cells and a critical regulator of gut barrier function, inflammation, and even gene expression — but supplementing it effectively is more complicated than it appears.
8 min read →